News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Faiz Kermani

Advertisement

Articles by Faiz Kermani

Evaluating the Impact of the Falsified Medicines Directive in Switzerland

ByFaiz Kermani
April 14th 2015

As the prevalence of falsified medicines continues to increase, Switzerland is taking measures to secure its supply chain such as the implementation of serialization.

Advertisement

Latest Updated Articles

  • Evaluating the Impact of the Falsified Medicines Directive in Switzerland
    Evaluating the Impact of the Falsified Medicines Directive in Switzerland

    April 14th 2015



Advertisement
Advertisement

Trending on PharmExec

1

Senate Democrats Expand Efforts to Expose Details of MFN Pharma Deals

2

Novo Nordisk Responds to FDA’s Warning Letter Regarding 2025 PADE Inspection

3

FDA Grants Priority Review to Enhertu as Treatment for Patients with HER2-positive Early Breast Cancer

4

Pharmaceutical Executive Daily: FDA Expands Approval of Leucovorin

5

FDA Approves Leucovorin Without a Clinical Trial for Cerebral Folate Transport Deficiency: Report

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us